TBD | 23andMe...And a Looming Data Disaster
What Next | Daily News and Analysis
00:00
The Troubled Journey of 23andMe
This chapter explores the dramatic decline of 23andMe, detailing its stock plunge, the risk of delisting, and the resignation of its board. It contrasts the company's promising inception aimed at democratizing genetic insights with the challenges it faced, including regulatory issues and the complexities of consumer DNA testing.
Transcript
Play full episode
